Literature DB >> 22781078

Long-acting reversible contraception for adolescents.

Colleen McNicholas1, Jeffrey F Peipert.   

Abstract

PURPOSE OF REVIEW: Teen pregnancy continues to plague the United States. This review will discuss long-acting reversible contraceptive (LARC) method use in teens, comprising intrauterine devices and subdermal implants. RECENT
FINDINGS: The American College of Obstetricians and Gynecologists along with the American Academy of Pediatrics, the Centers for Disease Control, and the World Health Organization have recognized the potential impact of LARC (comprising intrauterine contraception and subdermal implants) to reduce unintended pregnancies. They have affirmed the safety of such devices, and no effects on long-term fertility have been identified. Teen users of these methods have been shown to have high continuation and satisfaction rates. On the contrary, oral contraceptive pills, the patch, and the contraceptive vaginal ring have significantly higher contraceptive failure rates, and these rates are magnified in young women.
SUMMARY: LARC methods should be considered first-line options for teens seeking contraception.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781078      PMCID: PMC4183267          DOI: 10.1097/GCO.0b013e32835686d5

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  40 in total

1.  Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.

Authors:  Erika Baldaszti; Beate Wimmer-Puchinger; Kathleen Löschke
Journal:  Contraception       Date:  2003-02       Impact factor: 3.375

2.  Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use.

Authors:  J E Darroch; S Singh; J J Frost
Journal:  Fam Plann Perspect       Date:  2001 Nov-Dec

3.  New insights on the mode of action of intrauterine contraceptive devices in women.

Authors:  F Alvarez; V Brache; E Fernandez; B Guerrero; E Guiloff; R Hess; A M Salvatierra; S Zacharias
Journal:  Fertil Steril       Date:  1988-05       Impact factor: 7.329

4.  Effectiveness of long-acting reversible contraception.

Authors:  Brooke Winner; Jeffrey F Peipert; Qiuhong Zhao; Christina Buckel; Tessa Madden; Jenifer E Allsworth; Gina M Secura
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

5.  Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.

Authors:  J K Andersson; G Rybo
Journal:  Br J Obstet Gynaecol       Date:  1990-08

6.  Pain relief with naproxen following insertion of an intrauterine device.

Authors:  S E Massey; J C Varady; M R Henzl
Journal:  J Reprod Med       Date:  1974-12       Impact factor: 0.142

7.  Fertility after stopping use of intrauterine contraceptive device.

Authors:  M P Vessey; M Lawless; K McPherson; D Yeates
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

8.  Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.

Authors:  C G Nilsson; M Haukkamaa; H Vierola; T Luukkainen
Journal:  Clin Endocrinol (Oxf)       Date:  1982-12       Impact factor: 3.478

9.  IUD use and the risk of endometrial cancer.

Authors:  Abraham Benshushan; Ora Paltiel; Nathan Rojansky; Amnon Brzezinski; Neri Laufer
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-11-15       Impact factor: 2.435

10.  Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years.

Authors:  Margarete Hidalgo; Luis Bahamondes; Marcos Perrotti; Juan Diaz; Cecilia Dantas-Monteiro; Carlos Petta
Journal:  Contraception       Date:  2002-02       Impact factor: 3.375

View more
  9 in total

1.  Pregnancy intention and use of contraception among Hispanic women in the United States: data from the National Survey of Family Growth, 2006-2010.

Authors:  Lisa M Masinter; Joe Feinglass; Melissa A Simon
Journal:  J Womens Health (Larchmt)       Date:  2013-09-04       Impact factor: 2.681

2.  Determinants of Long-acting Reversible Contraception (LARC) Initial and Continued Use among Adolescents in the United States.

Authors:  C Emily Hendrick; Joshua N Cone; Jessica Cirullo; Julie Maslowsky
Journal:  Adolesc Res Rev       Date:  2019-07-12

3.  Impact of polymer crosslinking on release mechanisms from long-acting levonorgestrel intrauterine systems.

Authors:  Suraj Fanse; Quanying Bao; Yuan Zou; Yan Wang; Diane J Burgess
Journal:  Int J Pharm       Date:  2021-12-14       Impact factor: 6.510

4.  Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.

Authors:  Cameryn C Garrett; Louise A Keogh; Anne Kavanagh; Jane Tomnay; Jane S Hocking
Journal:  BMC Womens Health       Date:  2015-09-10       Impact factor: 2.809

5.  Leading With LARCs in Nigeria: The Stars Are Aligned to Expand Effective Family Planning Services Decisively.

Authors:  James D Shelton; Clea Finkle
Journal:  Glob Health Sci Pract       Date:  2016-06-27

6.  Use of and access to oral and injectable contraceptives in Brazil.

Authors:  Mareni Rocha Farias; Silvana Nair Leite; Noemia Urruth Leão Tavares; Maria Auxiliadora Oliveira; Paulo Sergio Dourado Arrais; Andréa Dâmaso Bertoldi; Tatiane da Silva Dal Pizzol; Vera Lucia Luiza; Luiz Roberto Ramos; Sotero Serrate Mengue
Journal:  Rev Saude Publica       Date:  2016-12       Impact factor: 2.106

7.  Factors associated with sexual and reproductive health behaviour of street-involved young people: findings from a baseline survey in Southwest Nigeria.

Authors:  Atinuke O Olaleye; Mary O Obiyan; Morenike O Folayan
Journal:  Reprod Health       Date:  2020-06-11       Impact factor: 3.223

8.  The Impact of Progestin-only Contraception on Adolescents with Macromastia.

Authors:  Laura C Nuzzi; Tannishtha Pramanick; Gabrielle G Massey; Landis R Walsh; Catherine T McNamara; Joseph M Firriolo; Amy D DiVasta; Brian I Labow
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-02-12

Review 9.  Lessons Learned from Longer Acting Reversible Contraception Applied to Longer Acting HIV Prevention Technologies.

Authors:  Rachel Logan; Dominika Seidman
Journal:  Curr HIV/AIDS Rep       Date:  2021-09-15       Impact factor: 5.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.